Rampart Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-829
Closed -$95K 94
2020
Q3
$95K Sell
829
-3,511
-81% -$415K 0.06% 260
2020
Q2
$495K Buy
4,340
+3,209
+284% +$340K 0.08% 259
2020
Q1
$91K Sell
1,131
-458
-29% -$47.4K 0.04% 343
2019
Q4
$170K Buy
1,589
+71
+5% +$7.4K 0.02% 474
2019
Q3
$162K Sell
1,518
-42
-3% -$4.31K 0.02% 460
2019
Q2
$159K Sell
1,560
-100
-6% -$9.61K 0.02% 475
2019
Q1
$149K Buy
1,660
+186
+13% +$16.1K 0.02% 476
2018
Q4
$123K Sell
1,474
-5,241
-78% -$491K 0.03% 361
2018
Q3
$163K Sell
6,715
-2,234
-25% -$245K 0.07% 294
2018
Q2
$984K Buy
8,949
+5,226
+140% +$544K 0.1% 264
2018
Q1
$373K Buy
3,723
+2,045
+122% +$209K 0.04% 371
2017
Q4
$165K Sell
1,678
-198
-11% -$18.8K 0.06% 327
2017
Q3
$176K Buy
1,876
+101
+6% +$10.7K 0.06% 339
2017
Q2
$197K Buy
1,775
+1,390
+361% +$147K 0.07% 302
2017
Q1
$38K Buy
+385
New +$36.7K 0.01% 318

Other funds holding DGX

Rampart Investment Management's DGX Position: Q4 2020 in Review

Rampart Investment Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 829 shares — an estimated $95K sold.

Rampart Investment Management first reported a position in DGX in Q1 2017 and held it in 15 quarters. The position peaked at $984K in Q2 2018. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Rampart Investment Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 829 Quest Diagnostics shares in Q4 2020, an estimated $95K.
  • Rampart Investment Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Quest Diagnostics position peaked at $984K in Q2 2018.
  • 812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.